Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Wellcome Foundation LtdfiledCriticalThe Wellcome Foundation Ltd
Publication of PY970077ApublicationCriticalpatent/PY970077A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La presente invención se refiere a análogos de nucleósidos de purina que contienen un anillo carbocíclico insaturado en lugar del resto de azúcar, derivados farmacéuticamente aceptables de los mismos y su uso en terapia médica, concretamente para el,tratamiento de ciertas infecciones virales.El documento FR-A-2626002 describe determinados isómeros ópticamente activos de nucleósidos de purina carbocíclicos, entre los que se incluye de carbovir,y su uso en el tratamiento del virus VIH carbovir.The present invention relates to purine nucleoside analogues containing an unsaturated carbocyclic ring in place of the sugar moiety, pharmaceutically acceptable derivatives thereof, and their use in medical therapy, specifically for the treatment of certain viral infections. Document FR-A-2626002 describes certain optically active isomers of carbocyclic purine nucleosides, including carbovir, and their use in the treatment of HIV.
USE OF AIB RIBOSIDE OR RIBOTIDE FOR THE MANUFACTURE OF A MEDICATION AGAINST CARDIAC CRISIS OR MYOCARDIAL INFARCTION IN PATIENTS SUFFERING FROM Atherosclerosis.